Nitta (5186) Q3 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2026 earnings summary
9 Feb, 2026Executive summary
Net sales for Q3 FY2025 increased 0.8% year-over-year to ¥67,401 million, with growth in most segments except Chemical Industrial Products.
Operating income rose 3.8% year-over-year to ¥4,278 million, while ordinary income declined 3.1% to ¥10,747 million.
Quarterly net income attributable to owners of parent decreased 2.4% year-over-year to ¥9,194 million.
Comprehensive income decreased 3.8% year-over-year to ¥10,494 million.
Overseas sales ratio increased to 33.8%, driven by strong demand in North America.
Financial highlights
Gross profit improved 4.4% year-over-year, reaching ¥19,056 million and a margin of 28.3%.
Capital expenditure for Q3 FY2025 was ¥2,318 million, with R&D expenditure at ¥1,699 million.
Depreciation for the period was ¥2,330 million.
Net income per share for the nine months was ¥332.65, down from ¥338.63 in the prior year.
Total assets as of December 31, 2025, were ¥186,615 million, up from ¥179,931 million at the previous fiscal year-end.
Outlook and guidance
FY2025 full-year forecast remains unchanged: net sales projected at ¥92,000 million (+1.9% YoY), operating income at ¥5,300 million (+2.8% YoY), and net income at ¥11,500 million (-5.2% YoY).
Net income per share for the full year is forecast at ¥414.01.
Annual dividend per share forecast is ¥145.00, up from ¥140.00 in the previous year.
Management notes forecasts are based on current information and assumptions, with actual results subject to various risks.
Latest events from Nitta
- Net income rose 16.3% on higher sales and cost controls, with higher dividends forecast.5186
Q2 202520 Nov 2025 - Comprehensive income rose 51.5% despite lower sales, aided by semiconductor demand and yen weakness.5186
Q1 202520 Nov 2025 - Net income rose 23.4% as profit growth and guidance improved, with higher dividends.5186
Q3 202520 Nov 2025 - Net income rose 23.1% as sales and operating income grew; global expansion remains a focus.5186
Q4 202520 Nov 2025 - Phase 2 targets ¥105B sales, 7% ROIC, global growth, and robust ESG and shareholder returns.5186
Corporate Presentation20 Nov 2025 - Flat sales, higher gross margin, but lower profits and comprehensive income due to rising costs and valuation losses.5186
Q1 202620 Nov 2025 - Flat sales and operating income, but net income fell 6% amid currency and cost headwinds.5186
Q2 202620 Nov 2025